Floatz logo

Prednisolone

Urinary System Neoplasm

Eli Lilly and CompanySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the Urinary System Neoplasm cohort.

Asset / SponsorPhaseRating
Normal Human Serum Albumin
Region Skane
Phase 4BB
Docetaxel
Sandy Srinivas
Phase 3BB
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Astellas Pharma Global Development, Inc.
Phase 2BB
Abiraterone
Eli Lilly and Company
Phase 3B
Volitinib
AstraZeneca
Phase 3B

View all 42 →

Same molecule, other indications

Prednisolone is also rated in:

infantile spasmsActive
BBB
Indicative · Phase 4
79 / 100
View asset →
non-Hodgkin lymphomaActive
BBB
Indicative · Phase 3
74 / 100
View asset →
lymphomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →